Location · Alabama
Clinical trials recruiting in Alabama
461 recruiting studies have at least one site in Alabama; 134 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Alabama.
461 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- Auburn, AL + 26 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- Auburn, AL + 18 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Op-T LLC
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Ages 18–50
- RecruitingPhase 3
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaukos Corporation
- Location
- Dothan, AL
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Mirador Therapeutics, Inc.
- Location
- Birmingham, AL + 42 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2/Phase 3
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
Takeda
- Location
- Birmingham, AL + 18 other US sites
- Eligibility basics
- Ages 16–70
- Recruiting
VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Stratpharma AG
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingPhase 3
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Rhythm Pharmaceuticals, Inc.
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 4+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 2
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Autobahn Therapeutics, Inc.
- Location
- Birmingham, AL + 31 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Huntsville, AL + 49 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 1
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
Pasithea Therapeutics Corp.
- Location
- Birmingham, AL
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited
- Location
- Birmingham, AL + 11 other US sites
- Eligibility basics
- Ages 40+
- Recruiting
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
Arsenal Medical, Inc.
- Location
- Birmingham, AL + 1 other US site
- Eligibility basics
- Ages 15+
- Recruiting
Access Cannulation Trial II
Voyager Biomedical
- Location
- Dothan, AL + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Endospan Ltd.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Medicure
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Any age listed
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
AB Science
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–81
- Recruiting
Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population
Owlet Baby Care, Inc.
- Location
- Birmingham, AL + 1 other US site
- Eligibility basics
- Ages 0 mo–1 mo
- RecruitingPhase 3
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Sumitomo Pharma Switzerland GmbH
- Location
- Mobile, AL + 101 other US sites
- Eligibility basics
- Ages 18–50 · Women only
- RecruitingPhase 2
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Glaukos Corporation
- Location
- Dothan, AL + 19 other US sites
- Eligibility basics
- Ages 2+
- RecruitingPhase 2
Study With Phage for CF Subjects With Pseudomonas Lung Infection
BiomX Ltd
- Location
- Birmingham, AL + 8 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Concept Medical Inc.
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 18–110